{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:54:11Z","timestamp":1788328451227,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MC\/UU\/00002\/11"],"award-info":[{"award-number":["MC\/UU\/00002\/11"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jinf.2023.04.015","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T11:17:35Z","timestamp":1682335055000},"page":"e8-e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England"],"prefix":"10.1016","volume":"87","author":[{"given":"Nurin","family":"Abdul Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie Grace","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6420-2539","authenticated-orcid":false,"given":"Asad","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9436-0626","authenticated-orcid":false,"given":"Tommy","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-6833","authenticated-orcid":false,"given":"Russell","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Lopez Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4606-5945","authenticated-orcid":false,"given":"Gavin","family":"Dabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0434-2724","authenticated-orcid":false,"given":"Simon","family":"Thelwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2023.04.015_bib1","doi-asserted-by":"crossref","unstructured":"Kang SW, Park H, Kim JY, Lim SY, Lee S, Bae JY, et al. Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1\/BA.2 and omicron BA.5 variants: a prospective cohort study. J Infect [Internet]; 2023 Jan 16 [cited 2023 Mar 3]. Available from: \u3008https:\/\/www.journalofinfection.com\/article\/S0163-4453(23)00020-8\/fulltext\u3009.","DOI":"10.1164\/ajrccm-conference.2023.207.1_MeetingAbstracts.A3840"},{"issue":"7923","key":"10.1016\/j.jinf.2023.04.015_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jinf.2023.04.015_bib3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S2213-2600(20)30161-2","article-title":"Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations","volume":"8","author":"Phua","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jinf.2023.04.015_bib4","doi-asserted-by":"crossref","unstructured":"Davies MA, Morden E, Rosseau P, Arendse J, Bam JL, Boloko L, et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. medRxiv; 2022, 2022.06.28.22276983.","DOI":"10.1016\/j.ijid.2022.11.024"},{"issue":"1","key":"10.1016\/j.jinf.2023.04.015_bib5","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1038\/s41467-022-33614-0","article-title":"Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa","volume":"13","author":"Wolter","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2023.04.015_bib6","doi-asserted-by":"crossref","unstructured":"Lewnard JA, Hong V, Kim JS, Shaw SF, Lewin B, Takhar H, et al. Association of SARS-CoV-2 BA.4\/BA.5 Omicron lineages with immune escape and clinical outcome [Internet]. medRxiv; 2022 [cited 2022 Nov 11]. p. 2022.07.31.22278258. Available from: \u3008https:\/\/www.medrxiv.org\/content\/10.1101\/2022.07.31.22278258v2\u3009.","DOI":"10.1101\/2022.07.31.22278258"},{"key":"10.1016\/j.jinf.2023.04.015_bib7","unstructured":"Hansen CH, Friis NU, Bager P, Stegger M, Fonager J, Fomsgaard A, et al. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark. Lancet Infect Dis [Internet]; 2022 [cited 2022 Nov 10]. Available from: \u3008https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(22)00595-3\/fulltext\u3009."},{"issue":"10","key":"10.1016\/j.jinf.2023.04.015_bib8","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S1473-3099(22)00572-2","article-title":"Variation in reported SARS-CoV-2 cases after testing policy changes","volume":"22","author":"Halford","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2023.04.015_bib9","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1038\/s41467-022-33740-9","article-title":"Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England","volume":"13","author":"Webster","year":"2022","journal-title":"Nat Commun"},{"issue":"10332","key":"10.1016\/j.jinf.2023.04.015_bib10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445323002499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445323002499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:36:37Z","timestamp":1759008997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445323002499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0163445323002499"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2023.04.015","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2023.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}